NEXTGEN BIOSCIENCE Trademark

Trademark Overview


On Wednesday, July 28, 2021, a trademark application was filed for NEXTGEN BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the NEXTGEN BIOSCIENCE trademark a serial number of 79319630. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, August 28, 2024. This trademark is owned by NEXTGEN Bioscience. The NEXTGEN BIOSCIENCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Laboratory research in the field of pharmaceuticals; Consultancy relating to pharmaceutical research and development; Pharmaceutical research and development; Research relating to medicines; Product testing in the nature of clinical testing of medicines; Medical research in the nature of conducting clinical studies of medicines; Pharmaceutical products evaluation; Pharmaceutical drug development services; Consultancy pertaining to pharmacology; Medical laboratory services; Medical research; Research and development of technology for medicinal chemical manufacturing; Medicine research; Testing of pharmaceuticals; Research relating to medical products; Providing information on the testing, inspection, and research of medical products; Research and development of vaccines and medicines; Research and development in the field of biotechnology
nextgen bioscience

General Information


Serial Number79319630
Word MarkNEXTGEN BIOSCIENCE
Filing DateWednesday, July 28, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "NEXTGEN BIOSCIENCE" where "NEXTGEN" is in teal and the wording "BIOSCIENCE" is in gray. To the left of the design are a blue oblong, a yellow oblong, and a green oblong intersecting, and the second stem of the second letter "N" in "NEXTGEN" extends below the letter in teal and above the letter in yellow.".
Indication of Colors claimedThe color(s) teal, gray, blue, yellow, and green is/are claimed as a feature of the mark.
NOT AVAILABLE"BIOSCIENCE"
Goods and ServicesDrug discovery services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Laboratory research in the field of pharmaceuticals; Consultancy relating to pharmaceutical research and development; Pharmaceutical research and development; Research relating to medicines; Product testing in the nature of clinical testing of medicines; Medical research in the nature of conducting clinical studies of medicines; Pharmaceutical products evaluation; Pharmaceutical drug development services; Consultancy pertaining to pharmacology; Medical laboratory services; Medical research; Research and development of technology for medicinal chemical manufacturing; Medicine research; Testing of pharmaceuticals; Research relating to medical products; Providing information on the testing, inspection, and research of medical products; Research and development of vaccines and medicines; Research and development in the field of biotechnology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEXTGEN Bioscience
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, September 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 17, 2021APPLICATION FILING RECEIPT MAILED
Monday, April 25, 2022ASSIGNED TO EXAMINER
Tuesday, May 3, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 4, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 7, 2022REFUSAL PROCESSED BY MPU
Tuesday, June 7, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 28, 2022REFUSAL PROCESSED BY IB
Tuesday, October 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 11, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 16, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 21, 2022SUSPENSION LETTER WRITTEN
Monday, November 21, 2022LETTER OF SUSPENSION E-MAILED
Monday, November 21, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022REFUSAL PROCESSED BY IB
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, March 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, June 2, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 27, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 28, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED